MD Per Bruno Jensen Dept. of Nephrology, Odense Universityhospital
Projektet i tal
OPEN undersøgelse/kliniske data
Forventet # af deltagere
Inkluderet antal deltagere
Inkluderede deltagere med prøver
The Effect of COVID-19 vaccination in hemodialysispatients - COVAC-HD
Earlier trials has shown severe difficulties in gaining an immunersponse after vaccination of people in hemodialysis.
This has been demonstarted after vaccinationtrials with traditional vaccines.
We set up an investtigation of the immunersponse in adult hemodialysispatients after vaccination with COVID-19 vaccine, no matter the type, to monitor the level of antibodies to COVID 19 at predefined intervals for the next two years.
Vaccination is difficult , because of reduced immunereponse in hemodialysis patients. The aim of this study was to investigate if the new vaccines could produce a better and perhaps even a sustained immunereponse, in adult hemodialysis patients.
Description of the cohort
The participants was included among adults with chronic kidney disease stadium 5d, recieving hemodialysis in the southern region of Denmark at the dept. of hemodialysis in Esbjerg, Kolding, Svendborg and Odense.
Data and biological material
Demografic data will be collected from the patients journal and blod samples will be drawn from the dialysisaccess.